CBA, CSL, ResMed too expensive, says Maple Brown
Price falls for CSL, ResMed and Macquarie show that following the herd to buy defensive businesses may produce suboptimal returns if you pay too much.
Source: afr.com
📰 Lazard Select News
Lazard Select News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lazard Select. Real-time updates on events, politics, business and more.